Chronic phosphodiesterase type 2 inhibition improves memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease

Annerieke S. R. Sierksma, Kris Rutten, Sebastian Sydlik, Somayeh Rostamian, Harry W. M. Steinbusch, Daniel L. A. van den Hove, Jos Prickaerts

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)124-136
JournalNeuropharmacology
Volume64
DOIs
Publication statusPublished - Jan 2013

Keywords

  • Phosphodiesterase inhibitors (PDEIs)
  • Alzheimer's disease (AD)
  • Cognition
  • CREB
  • BDNF
  • APPswe/PS1dE9

Cite this